• About
  • Team
  • Portfolio
  • Careers
  • Recent News
  • Contact
  • About
  • Team
  • Portfolio
  • Careers
Avalon BioVentures
  • Recent News
  • Contact

Recent News

filter by Type:
PORTFOLIO NEWS
Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital
April 30, 2024
PORTFOLIO NEWS
Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors
February 26, 2024
PORTFOLIO NEWS
Jnana Therapeutics Announces Positive Clinical Proof of Concept Achieved with JNT-517, a Potential First-in-Class Oral Treatment for PKU
January 30, 2024
PORTFOLIO NEWS
FibroGen Enters into Exclusive License for FOR46 with Fortis Therapeutics
May 08, 2023
AVALON NEWS
Avalon BioVentures Raises First Fund Dedicated to Early-Stage Biotech Investments
December 06, 2022
1 2
avalon footer logo

Cultivating tomorrow’s life science breakthroughs… Today.

Avalon Bioventures

11099 N. Torrey Pines Rd.
Suite 290
La Jolla, CA 92037

Social: LinkedIn

©2025 Avalon BioVentures.Privacy Policy Terms of Use Website by 22 Fillmore

This site uses cookies to provide a better browsing experience. More information can be found on our Privacy Policy page.

Accept